While artificial intelligence (AI)-powered screening has been validated for diabetic retinopathy, applying the technology to glaucoma has proved more challenging because glaucoma is not one disease. A glaucoma diagnosis is based on a constellation of symptoms, diagnostic tests, and longitudinal data.